272 related articles for article (PubMed ID: 23498953)
1. Leishmania donovani targets Dicer1 to downregulate miR-122, lower serum cholesterol, and facilitate murine liver infection.
Ghosh J; Bose M; Roy S; Bhattacharyya SN
Cell Host Microbe; 2013 Mar; 13(3):277-88. PubMed ID: 23498953
[TBL] [Abstract][Full Text] [Related]
2. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
Choudhury R; Das P; De T; Chakraborti T
Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
[TBL] [Abstract][Full Text] [Related]
3. Reduced pathogenicity of fructose-1,6-bisphosphatase deficient Leishmania donovani and its use as an attenuated strain to induce protective immunogenicity.
Saini S; Ghosh AK; Das S; Singh R; Abhishek K; Verma S; Kumar A; Mandal A; Purkait B; Sinha KK; Das P
Vaccine; 2018 Feb; 36(9):1190-1202. PubMed ID: 29395522
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-21 Deficiency Promotes the Early Th1 Immune Response and Resistance toward Visceral Leishmaniasis.
Varikuti S; Verma C; Holcomb E; Jha BK; Viana A; Maryala R; Lamenza F; McElwain BK; Doni NY; Papenfuss T; Oghumu S; Gannavaram S; Nakhasi HL; Satoskar AR
J Immunol; 2021 Sep; 207(5):1322-1332. PubMed ID: 34341171
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression profiling of dibenzalacetone (DBA) treated intracellular amastigotes of Leishmania donovani.
Singh N; Chauhan IS
Exp Parasitol; 2018 Oct; 193():5-19. PubMed ID: 30125570
[TBL] [Abstract][Full Text] [Related]
6. Potency, efficacy and durability of DNA/DNA, DNA/protein and protein/protein based vaccination using gp63 against Leishmania donovani in BALB/c mice.
Mazumder S; Maji M; Das A; Ali N
PLoS One; 2011 Feb; 6(2):e14644. PubMed ID: 21311597
[TBL] [Abstract][Full Text] [Related]
7. Histopathological and immunohistochemical characterisation of hepatic granulomas in Leishmania donovani-infected BALB/c mice: a time-course study.
Salguero FJ; Garcia-Jimenez WL; Lima I; Seifert K
Parasit Vectors; 2018 Jan; 11(1):73. PubMed ID: 29386047
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression profiling of Leishmania donovani-infected host cells uncovers the regulatory role of MIR30A-3p in host autophagy.
Singh AK; Pandey RK; Shaha C; Madhubala R
Autophagy; 2016 Oct; 12(10):1817-1831. PubMed ID: 27459332
[TBL] [Abstract][Full Text] [Related]
9. Leishmaniasis in Turkey: Visceral and cutaneous leishmaniasis caused by Leishmania donovani in Turkey.
Özbilgin A; Harman M; Karakuş M; Bart A; Töz S; Kurt Ö; Çavuş İ; Polat E; Gündüz C; Van Gool T; Özbel Y
Acta Trop; 2017 Sep; 173():90-96. PubMed ID: 28587839
[TBL] [Abstract][Full Text] [Related]
10. DDX3 DEAD-box RNA helicase (Hel67) gene disruption impairs infectivity of Leishmania donovani and induces protective immunity against visceral leishmaniasis.
Pandey SC; Pande V; Samant M
Sci Rep; 2020 Oct; 10(1):18218. PubMed ID: 33106577
[TBL] [Abstract][Full Text] [Related]
11. Retinoic Acid Increases Cellular Cholesterol in Leishmania donovani-Infected Macrophages in an mTOR-Independent Manner.
Prakash S; Rai AK
Microbiol Spectr; 2022 Dec; 10(6):e0269922. PubMed ID: 36264252
[TBL] [Abstract][Full Text] [Related]
12. Involvement of CD4⁺ Foxp3⁺ regulatory T cells in persistence of Leishmania donovani in the liver of alymphoplastic aly/aly mice.
Tiwananthagorn S; Iwabuchi K; Ato M; Sakurai T; Kato H; Katakura K
PLoS Negl Trop Dis; 2012; 6(8):e1798. PubMed ID: 22928057
[TBL] [Abstract][Full Text] [Related]
13. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
[TBL] [Abstract][Full Text] [Related]
14. Dicer1/miR-29/HMGCR axis contributes to hepatic free cholesterol accumulation in mouse non-alcoholic steatohepatitis.
Liu MX; Gao M; Li CZ; Yu CZ; Yan H; Peng C; Li Y; Li CG; Ma ZL; Zhao Y; Pu MF; Miao LL; Qi XM; Ren J
Acta Pharmacol Sin; 2017 May; 38(5):660-671. PubMed ID: 28112179
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Glycolysis Is Required for Antileishmanial Functions of Neutrophils Upon Infection With
Ohms M; Ferreira C; Busch H; Wohlers I; Guerra de Souza AC; Silvestre R; Laskay T
Front Immunol; 2021; 12():632512. PubMed ID: 33815385
[TBL] [Abstract][Full Text] [Related]
16. Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease.
Sharma H; Estep M; Birerdinc A; Afendy A; Moazzez A; Elariny H; Goodman Z; Chandhoke V; Baranova A; Younossi ZM
J Gastroenterol Hepatol; 2013 Aug; 28(8):1410-5. PubMed ID: 23663110
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome Analysis Identifies Immune Markers Related to Visceral Leishmaniasis Establishment in the Experimental Model of BALB/c Mice.
Agallou M; Athanasiou E; Kammona O; Tastsoglou S; Hatzigeorgiou AG; Kiparissides C; Karagouni E
Front Immunol; 2019; 10():2749. PubMed ID: 31849951
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil elastase promotes
Dias BT; Dias-Teixeira KL; Godinho JP; Faria MS; Calegari-Silva T; Mukhtar MM; Lopes U; Mottram JC; Lima APCA
FASEB J; 2019 Oct; 33(10):10794-10807. PubMed ID: 31284755
[TBL] [Abstract][Full Text] [Related]
19. Pathological roles of MRP14 in anemia and splenomegaly during experimental visceral leishmaniasis.
Ishizuka K; Fujii W; Azuma N; Mizobuchi H; Morimoto A; Sanjoba C; Matsumoto Y; Goto Y
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0008020. PubMed ID: 31961866
[TBL] [Abstract][Full Text] [Related]
20. Ly6C
Terrazas C; Varikuti S; Oghumu S; Steinkamp HM; Ardic N; Kimble J; Nakhasi H; Satoskar AR
Sci Rep; 2017 Oct; 7(1):14693. PubMed ID: 29089636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
